Clinical characteristics, susceptibility profiles, and outcomes of infection with Alternaria species: a 14-year retrospective study. (PubMed, Med Mycol) - Sep 8, 2026 - "Posaconazole and itraconazole demonstrated low MICs (MIC₅₀/MIC₉₀: 0.06/0.5 and 0.25/0.5 µg/mL, respectively). Voriconazole and isavuconazole showed higher MIC₅₀/MIC₉₀ (1/2 and 2/4 µg/mL)...Interpretive criteria for Alternaria spp. are needed to guide empiric and definitive therapy."
Journal • Retrospective data • Hematological Disorders • Hematological Malignancies • Immunology • Infectious Disease • Oncology • Solid Organ Transplantation • Transplantation
|
|
Aditya S Shah; Austin B Auyeung; Joya-Rita Hindy; Nancy L Wengenack; Nischal Ranganath; Ryan W Stevens; Sharon M Deml
|